Clinical Trial Update: Rosuvastatin for Hepatitis C [NA]

View source ↗

Summary

A clinical trial evaluating rosuvastatin for hepatitis C conducted by UMC Utrecht has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: UMC Utrecht | Conditions: Hepatitis C | NA | Status: WITHDRAWN